Literature DB >> 24425691

Molecular characterization and clinical impact of t(11;15)(q23;q14-15) MLL-CASC5 rearrangement.

John Jeongseok Yang1, Tae Sung Park, Seung-Tae Lee, Ja-Young Seo, Seung Hwan Oh, Eun Hae Cho, Sabine Strehl, Nora Mühlegger, Michael N Dworzak, Jan Zuna, Dagmar Pospisilova, Claus Meyer, Rolf Marschalek, Hee-Jin Kim, Sun-Hee Kim.   

Abstract

Entities:  

Keywords:  CASC5; MLL; chromosome 3 abnormality; hematologic malignancies; t(11;15)

Mesh：

Substances：

Year:  2014        PMID： 24425691      PMCID： PMC4007919          DOI： 10.3324/haematol.2013.095638

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia.

Authors:  V Grossmann; S Schnittger; F Poetzinger; A Kohlmann; A Stiel; C Eder; A Fasan; W Kern; T Haferlach; C Haferlach
Journal:  Leukemia       Date:  2013-03-28       Impact factor: 11.528

2.  AF15q14, a novel partner gene fused to the MLL gene in an acute myeloid leukaemia with a t(11;15)(q23;q14).

Authors:  S Hayette; I Tigaud; A Vanier; S Martel; L Corbo; C Charrin; E Beillard; G Deleage; J P Magaud; R Rimokh
Journal:  Oncogene       Date:  2000-09-07       Impact factor: 9.867

3.  Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations.

Authors:  T Burmeister; R Marschalek; B Schneider; C Meyer; N Gökbuget; S Schwartz; D Hoelzer; E Thiel
Journal:  Leukemia       Date:  2006-03       Impact factor: 11.528

4.  A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15.

Authors:  Vandana Chinwalla; Andy Chien; Maria Odero; Mary Beth Neilly; Nancy J Zeleznik-Le; Janet D Rowley
Journal:  Oncogene       Date:  2003-03-06       Impact factor: 9.867

Review 5.  Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore.

Authors:  Emily A Foley; Tarun M Kapoor
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01       Impact factor: 94.444

6.  Spontaneous remission of acute myeloid leukemia relapse after hematopoietic cell transplantation in a high-risk patient with 11q23/MLL abnormality.

Authors:  Michael Hudecek; Kristina Bartsch; Nadja Jäkel; Simone Heyn; Roald Pfannes; Haifa Kathrin Al-Ali; Michael Cross; Wolfram Pönisch; Ulrich Gerecke; Jeanett Edelmann; Thomas Ittel; Dietger Niederwieser
Journal:  Acta Haematol       Date:  2008-03-27       Impact factor: 2.195

7.  Kinetochore KMN network gene CASC5 mutated in primary microcephaly.

Authors:  Anne Genin; Julie Desir; Nelle Lambert; Martine Biervliet; Nathalie Van Der Aa; Genevieve Pierquin; Audrey Killian; Mario Tosi; Montse Urbina; Anne Lefort; Frederick Libert; Isabelle Pirson; Marc Abramowicz
Journal:  Hum Mol Genet       Date:  2012-09-13       Impact factor: 6.150

8.  Translocation (11;15)(q23;q14) in three patients with acute non-lymphoblastic leukemia (ANLL): clinical, cytogenetic and molecular studies.

Authors:  J M Hernández; C Mecucci; H B Beverloo; L Selleri; I Wlodarska; M Stul; L Michaux; G Verhoef; A Van Orshoven; J J Cassiman
Journal:  Leukemia       Date:  1995-07       Impact factor: 11.528

9.  The MLL recombinome of acute leukemias in 2013.

Authors:  C Meyer; J Hofmann; T Burmeister; D Gröger; T S Park; M Emerenciano; M Pombo de Oliveira; A Renneville; P Villarese; E Macintyre; H Cavé; E Clappier; K Mass-Malo; J Zuna; J Trka; E De Braekeleer; M De Braekeleer; S H Oh; G Tsaur; L Fechina; V H J van der Velden; J J M van Dongen; E Delabesse; R Binato; M L M Silva; A Kustanovich; O Aleinikova; M H Harris; T Lund-Aho; V Juvonen; O Heidenreich; J Vormoor; W W L Choi; M Jarosova; A Kolenova; C Bueno; P Menendez; S Wehner; C Eckert; P Talmant; S Tondeur; E Lippert; E Launay; C Henry; P Ballerini; H Lapillone; M B Callanan; J M Cayuela; C Herbaux; G Cazzaniga; P M Kakadiya; S Bohlander; M Ahlmann; J R Choi; P Gameiro; D S Lee; J Krauter; P Cornillet-Lefebvre; G Te Kronnie; B W Schäfer; S Kubetzko; C N Alonso; U zur Stadt; R Sutton; N C Venn; S Izraeli; L Trakhtenbrot; H O Madsen; P Archer; J Hancock; N Cerveira; M R Teixeira; L Lo Nigro; A Möricke; M Stanulla; M Schrappe; L Sedék; T Szczepański; C M Zwaan; E A Coenen; M M van den Heuvel-Eibrink; S Strehl; M Dworzak; R Panzer-Grümayer; T Dingermann; T Klingebiel; R Marschalek
Journal:  Leukemia       Date:  2013-04-30       Impact factor: 11.528

10.  Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse.

Authors:  Thomas Burmeister; Mara Molkentin; Claus Meyer; Nils Lachmann; Stefan Schwartz; Birte Friedrichs; Jörg Beyer; Igor Wolfgang Blau; Gunnar Lohm; Carola Tietze-Bürger; Rolf Marschalek; Lutz Uharek
Journal:  Exp Hematol Oncol       Date:  2012-04-18
View more
  1 in total

1.  Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences.

Authors:  E Waanders; B Scheijen; M C J Jongmans; H Venselaar; S V van Reijmersdal; A H A van Dijk; A Pastorczak; R D A Weren; C E van der Schoot; M van de Vorst; E Sonneveld; N Hoogerbrugge; V H J van der Velden; B Gruhn; P M Hoogerbrugge; J J M van Dongen; A Geurts van Kessel; F N van Leeuwen; R P Kuiper
Journal:  Leukemia       Date:  2016-10-13       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.